Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

NCT01478308 is registered in ClinicalTrials.gov with New Mexico Cancer Research Alliance as lead sponsor.

NCT NCT01478308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01478308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer
Lead sponsor
New Mexico Cancer Research Alliance
Phase
Phase 2
Overall status
Withdrawn
Start date
June 30, 2011
Completion date
October 31, 2011
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer